Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

It's important to keep in mind that Buffett's words and actions don't always follow the path of the majority. This top ...

On Friday, Pfizer Inc (PFE) stock saw a decline, ending the day at $26.59 which represents a decrease of $-0.02 or -0.08% from the prior close of $26.61. The stock opened at $26.7 and touched a low of ...

Oliver Luxxe Assets LLC lifted its position in Pfizer Inc. (NYSE:PFE – Free Report) by 2.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...

A patient-led study examines the potential of extended Paxlovid courses for Long COVID relief, documenting varied outcomes ...

Pfizer plans to achieve $4 billion in savings, invest in key areas like oncology and vaccines, and project double-digit EPS ...

Check the time stamp on this data. Updated AI-Generated Signals for Pfizer Inc. (PFE) available here: PFE.

Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.4% during trading on Wednesday . The stock traded as high as $26.65 and ...

Pfizer (PFE) closed the latest trading day at $26.61, indicating a +0.3% change from the previous session's end. The stock's performance was ahead of the S&P 500's daily loss of 0.22%. Elsewhere ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...